BioResonator IOP device receives CE-approval – European launch begins

The BioResonator tonometer has received the official CE approval required to sell the first product in the EU. The international product launch in North America and Asia has already started, and the recent CE approval means that Europe is now first in line.”Our accurate instruments are so simple to use that we are convinced of a strong impact, primarily in the eye specialist group, but also as an important screening and follow up tool in primary care,” says Mikael Lindblad, CEO of Umeå-based company BioResonator AB. A high IOP can be a sign of glaucoma, a disease that entails permanent